搜尋
亞培
ABT添加自選
114.140USD
-0.290-0.25%
收盤 08-20 16:00（美東）
197.61B總市值
31.69本益比TTM
關於 亞培 公司
亞培是一家橫跨全球的醫療保健領導者，專注於多元健康產品的研發、製造與銷售，業務框架涵蓋四大單元：成熟藥品、診斷、營養以及醫療器械。成熟藥品單元負責多品牌仿製藥的國際行銷；診斷單元向血庫、醫院、商業實驗室與替代護理點提供檢測系統與試劑；營養單元經營成人及兒童營養品全球通路；醫療器械單元銷售節律管理、電生理、心衰、血管、結構心臟、神經調控及糖尿病護理裝置，持續推動創新改善患者生命品質。其全球供應鏈覆蓋六大洲，利用數據分析與可持續製造提升效率與品質保障。
亞培 簡介
公司代碼ABT
公司名稱Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
員工數量114000
證券類型Ordinary Share
年結日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編60064-3500
電話12246676100
網址https://www.abbott.com
公司代碼ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
亞培公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
70.72K
-8.27%
Ms. Nancy McKinstry
Ms. Nancy McKinstry
Lead Independent Director
Lead Independent Director
41.01K
+5.57%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Mr. Eric Shroff
Mr. Eric Shroff
Senior Vice President - Rapid and Molecular Diagnostics
Senior Vice President - Rapid and Molecular Diagnostics
39.16K
-1.81%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%
常見問題
亞培的前五大股東是誰？
亞培的前五大股東如下：Mr. Daniel J. Starks
有多少機構持有亞培(ABT)的股份？
截至2026Q1，共有4859家機構持有亞培的股份，合計持有的股份價值約為1.25B，占公司總股份的71.75% 。與2025Q4相比，機構持股有所增加，增幅為-187252308.00。
哪個業務部門對亞培的收入貢獻最大？
在2026Q1，Diabetes Care業務部門對亞培的收入貢獻最大，創收8.00B，占總收入的18.04% 。